The Battle for the Brain: Could Niacin Be the Key to Unlocking Glioblastoma Treatment? on October 4, 2026 Posted by
New Dawn for Sleep Medicine: Japan Approves WAKIX as First Non-Scheduled Treatment for Excessive Daytime Sleepiness on October 4, 2026 Posted by
The Biology of Resilience: Harnessing Oxytocin to Navigate Modern Uncertainty on October 2, 2026 Posted by
A Unified Front Against Chronic Disease: European Parliament Backs Landmark Cardiovascular and Respiratory Health Strategy on October 2, 2026 Posted by
The Silent Struggle: Unmasking the Prevalence of Dysphagia in EDS and HSD on October 2, 2026 Posted by
The Hidden Cost of Shelf Life: New Study Links Common Food Preservatives to Cardiovascular Risk on October 2, 2026 Posted by
Understanding Obsessive-Compulsive Disorder: A Comprehensive Guide to Symptoms, Causes, and Modern Treatment on October 2, 2026 Posted by
The Battle for the Brain: Could Niacin Be the Key to Unlocking Glioblastoma Treatment? on October 4, 2026 Posted by
New Dawn for Sleep Medicine: Japan Approves WAKIX as First Non-Scheduled Treatment for Excessive Daytime Sleepiness on October 4, 2026 Posted by
The Biology of Resilience: Harnessing Oxytocin to Navigate Modern Uncertainty on October 2, 2026 Posted by
A Unified Front Against Chronic Disease: European Parliament Backs Landmark Cardiovascular and Respiratory Health Strategy on October 2, 2026 Posted by
Posted in Digital Health Tools The FDA in Flux: Dr. Marty Makary’s Departure, Ethical Quandaries, and the Future of Pharmaceutical Policy on June 4, 2026
Posted in Medical Innovations Transition at the Helm: Speculation Swirls Over FDA’s Permanent Leadership Following Makary Resignation on May 20, 2026 rifanmuazin
Posted in Medical Innovations The Unraveling of the FDA: Lessons from the Resignation of Marty Makary on May 17, 2026 rifanmuazin
Posted in Digital Health Tools The End of an Era: Marty Makary Resigns as FDA Commissioner Amid Unprecedented Agency Volatility on May 14, 2026 rifanmuazin
Posted in Digital Health Tools A Tenure of Turbulence: Marty Makary Resigns as FDA Commissioner Amid Agency Instability on May 14, 2026 rifanmuazin
Posted in Medical Innovations The Search for a New FDA Commissioner: Rebuilding Trust in a Post-Makary Era on May 14, 2026 rifanmuazin
Posted in Medical Innovations The FDA at a Crossroads: Trump Administration Launches Urgent Search for New Commissioner Following Makary Resignation on May 13, 2026 rifanmuazin
Posted in Digital Health Tools The Legacy of a Disrupted Agency: Analyzing the Tenure of FDA Commissioner Marty Makary on May 13, 2026 rifanmuazin
Posted in Caregiver Support The Tumultuous Tenure Ends: FDA Commissioner Dr. Marty Makary Resigns Amid Agency-Wide Crisis on May 12, 2026 rifanmuazin
Posted in Medical Innovations The Tumultuous Exit: Marty Makary Resigns as FDA Commissioner Amid Internal Strife and Political Pressure on May 12, 2026 rifanmuazin
